FAST-CLEAR

Welcome to the Brand page for “FAST-CLEAR”, which is offered here for Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use;bifunctional chelate material to be used in drug discovery, pharmaceutical development and clinical research;.

Its status is currently believed to be active. Its class is unavailable. “FAST-CLEAR” is believed to be currently owned by “Fusion Pharmaceuticals Inc.”